|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2303875 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09766158.1 |
| Europos patento paraiškos padavimo data | 2009-06-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2009/050695 |
| Data | 2009-06-18 |
| (87) | Numeris | WO 2009/153597 |
| Data | 2009-12-23 |
| (30) | Numeris | Data | Šalis |
| 74188 | 2008-06-20 | US | |
| 152350 | 2009-02-13 | US |
| (72) |
BLADE, Helen, GB
CHURCHILL, Gwydion, Huw, GB
CURRIE, Angela, Charlotte, GB
DOBSON, Benjamin, Charles, GB
HYNES, Peter, Samuel, GB
KENWORTHY, Martin, Neal, GB
POWELL, Lyn, GB
RAW, Steven, Anthony, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | COMPOSITIONS WITH AND PROCESS FOR METHYLMORPHOLIN-SUBSITUTED PYRIDO[2,3-D]PYRIMIDINES |
| COMPOSITIONS WITH AND PROCESS FOR METHYLMORPHOLIN-SUBSITUTED PYRIDO[2,3-D]PYRIMIDINES |